- Home
- NVCR vs STAA Comparison
NVCR vs STAA Comparison
Compare NVCR & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVCR | STAA |
|---|---|---|
| Founded | 2000 | 1982 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.1B |
| IPO Year | 2015 | 1995 |
Fundamental Metrics
Financial Performance| Metric | NVCR | STAA |
|---|---|---|
| Price | $15.26 | $22.17 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 12 |
| Target Price | $27.14 | ★ $27.70 |
| AVG Volume (30 Days) | ★ 1.0M | 845.1K |
| Earning Date | 10-29-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.79 | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | ★ $655,353,000.00 | $239,442,000.00 |
| Revenue This Year | $10.76 | $39.61 |
| Revenue Next Year | $10.88 | $7.86 |
| P/E Ratio | ★ N/A | $86.81 |
| Revenue Growth | ★ 8.28 | N/A |
| 52 Week Low | $9.82 | $15.59 |
| 52 Week High | $21.45 | $35.87 |
Technical Indicators
Market Signals| Indicator | NVCR | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 35.46 | 49.29 |
| Support Level | $14.93 | $21.72 |
| Resistance Level | $15.19 | $24.31 |
| Average True Range (ATR) | 0.56 | 0.89 |
| MACD | -0.10 | 0.27 |
| Stochastic Oscillator | 23.46 | 78.06 |
Price Performance
Historical ComparisonAbout NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.